OrbiMed’s Medtronic MDT Stock Holding History

OrbiMed’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-254,200	Closed	-$20.5M	–	147
2017 Q4	$20.5M	Sell	254,200 -624,800	-71%	-$50M	0.26%	79
2017 Q3	$68.4M	Hold	879,000	–	–	0.65%	46
2017 Q2	$78M	Buy	879,000 +112,400	+15%	+$9.48M	0.82%	41
2017 Q1	$61.8M	Hold	766,600	–	–	0.7%	45
2016 Q4	$54.6M	Hold	766,600	–	–	0.7%	46
2016 Q3	$66.2M	Buy	766,600 +100,301	+15%	+$8.74M	0.75%	49
2016 Q2	$57.8M	Hold	666,299	–	–	0.6%	48
2016 Q1	$50M	Buy	666,299 +78,000	+13%	+$5.87M	0.53%	48
2015 Q4	$45.3M	Hold	588,299	–	–	0.41%	54
2015 Q3	$39.4M	Sell	588,299 -58,001	-9%	-$4.27M	0.4%	51
2015 Q2	$47.9M	Buy	+646,300	New	+$49.4M	0.4%	55
2015 Q1	–	Sell	-493,800	Closed	-$37.4M	–	138
2014 Q4	$35.7M	Buy	493,800 +70,500	+17%	+$4.9M	0.34%	61
2014 Q3	$26.2M	Hold	423,300	–	–	0.27%	65
2014 Q2	$27M	Buy	423,300 +100,300	+31%	+$6.09M	0.32%	57
2014 Q1	$19.9M	Hold	323,000	–	–	0.24%	66
2013 Q4	$18.5M	Sell	323,000 -87,000	-21%	-$4.93M	0.27%	66
2013 Q3	$21.8M	Buy	410,000 +217,700	+113%	+$11.7M	0.39%	52
2013 Q2	$9.9M	Buy	+192,300	New	+$9.51M	0.21%	77

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

OrbiMed's MDT Position: Q1 2018 in Review

OrbiMed sold out of Medtronic (MDT) in Q1 2018, closing a stake of 254,200 shares — an estimated $20.5M sold.

OrbiMed first reported a position in MDT in Q2 2013 and held it in 18 quarters. The position peaked at $78M in Q2 2017. 1,381 funds tracked by Wall St. Rank hold MDT as of Q1 2018.

OrbiMed reported no remaining Medtronic position as of Q1 2018 after selling out during the quarter.
OrbiMed sold 254,200 Medtronic shares in Q1 2018, an estimated $20.5M.
OrbiMed first reported a position in Medtronic in Q2 2013 and held it in 18 quarters.
OrbiMed's Medtronic position peaked at $78M in Q2 2017.
1,381 funds tracked by Wall St. Rank held Medtronic as of Q1 2018.

Based on OrbiMed's 13F filing for Q1 2018, filed 15 May 2018.